Get the tools used by (smart)2 investors.

EPS Diluted Cumulative Growth (3y) for Johnson & Johnson

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

JNJ: Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...

161.72 USD
Price
USD
Fair Value
Upside
140.68 - 169.99
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Johnson & Johnson's EPS Diluted Cumulative Growth (3y):

JNJHLTH.USBMYMRKLLYNVSTLPH-200.0%-100.0%0.0%100.0%

Performance Summary
  • Johnson & Johnson's eps diluted cumulative growth (3y) is -13.1%

How does J&J's EPS Diluted Cumulative Growth (3y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Johnson & Johnson because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: EPS Diluted Cumulative Growth (3y)

Hide this widget
eps_diluted_cont_cumul_growth_3y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EPS Diluted Cumulative Growth (3y) in the growth category include:

View Full List

Search for metric or datapoint

EPS Diluted Cumulative Growth (3y)

Cumulative diluted EPS growth over the last three years

Definition of EPS Diluted Cumulative Growth (3y)

Hide this widget
Cumulative diluted EPS growth over the last three years

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-1,215.9%-815.9%-415.9%371.5%0200400

The chart above depicts the distribution of eps diluted cumulative growth (3y) for companies operating in the Healthcare sector in the Developed economic region. Over 2,260 companies were considered in this analysis, and 2,178 had meaningful values. The average eps diluted cumulative growth (3y) of companies in the sector is -20.3% with a standard deviation of 174.5%.

Johnson & Johnson's EPS Diluted Cumulative Growth (3y) of -13.1% ranks in the 35.9% percentile for the sector. The following table provides additional summary stats:

EPS Diluted Cumulative Growth (3y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,268
Included Constituents2,178
Min-1,276.9%
Max341.4%
Median25.3%
Mean-20.3%
Standard Deviation174.5%

You can find companies with similar eps diluted cumulative growth (3y) using this stock screener.

All rights reserved. Terms Of Use